Safe and efficacious use of Bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition

American Journal of Cardiology

Volumn 91, Issue 6, 2003, Pages 742-743

  Cho, Leslie ^a   Chew, Derek P ^b   Moliterno, David J ^b   Roffi, Marco ^b   Ellis, Stephen G ^b   Franco, Irving ^b   Bajzer, Christopher ^b   Bhatt, Deepak L ^b   Dorosti, Khosrow ^b   Simpfendorder, Conrad ^b   Tuzcu, Murat ^b   Yadav, Jay S ^b   Brener, Sorin ^b   Raymond, Russell ^b   Whitlow, Patrick ^b   Topol, Eric J ^b   Lincoff, A Michael ^b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; ISOENZYME;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOTTING TIME; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS SURGERY; DEATH; DEVICE; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATICS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; Q WAVE; STENT; TREATMENT OUTCOME;

EID: 0037443581     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03420-3     Document Type: Article

References (4)

1. Lefkovits J., Topol E.J. Direct thrombin inhibitors in cardiovascular medicine. Circulation. 90:1994;1522-1536.
2. Bittl J.A., Strony J., Brinker J.A., Ahmed W.H., Meckel C.R., Chaitman B.R., Marnganore J., Deutsch E., Adelman B. Treatment with bivalirudin (hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. N Engl J Med. 333:1995;764-769.
3. Bittl J.A., Chaitman B.R., Feit F., Kimball W., Topol E.J. Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina final report reanalysis of the Bivalirudin Angioplasty Study. Am Heart J. 142:2001;952-960.
4. Lincoff A.M., Kleiman N.S., Kottke-Marchant K., Maierson E.S., Maresh K., Wolski K.E., Topol E.J. Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization results of the Comparison of Abciximab Complications with Hirulog for ischemic Events Trial (CACHET). Am Heart J. 143:2002;847-853.